Open-House Biologika Discount Contracts 2025-16-Agalsidase Alfa

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 109662867

  Document Type - Tender Notices

Description - Description: The funds involved pursue the goal of concluding discount contracts according to § 130a (8) SGB V with all suitable pharmaceutical entrepreneurs to the active ingredient Agalsidase alfa. The conclusion of the contract takes place as par t of the open house biological procedure of the funds involved: Individual negotiations on contract content are not conducted, uniform conditions apply. The health insurance companies involved do not allow individual contractual partners to exclusiveness. The contract term is a maximum of 24 months starting on July 1st, 2025. The contract ends at the latest on June 30, 2027, regardless of the date of the conclusion of the contract. All further in

Gt Ref Id - 109662867

Deadline - Jun 30, 2027